Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Prostate > MPR761a
  • Cores:
    76
    CASES:
    35
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    10
    Tissue Array Type:
    FFPE
    Species:
    Human
MPR761a
$295.00
Add To Collect

Description: Prostate cancer with matched cancer adjacent tissue array, including pathology grade, TNM, clinical stage, Gleason grade and Gleason scores, 35 cases/76 cores, replacing MPR761

Details: Prostate carcinoma with matched cancer adjacent tissue microarray, containing 35 cases of adenocarcinoma with 3 matched cancer adjacent tissue, single cores per block

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Malignant()
  • Malignant(I)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(III)
  • Malignant(IV)
  • AT(-)
TISSUE ARRAYS
MPR761a
1
2
3
4
5
6
7
8
9
10
A
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
B
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
C
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
D
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
E
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
F
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
G
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
H
Pro
Pro
Pro
Pro
Pro
Pro
MPR761a
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size Gleason Grade Gleason Score
A1
1 71 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant - 1 3+3
A2
2 71 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant - 1 2+2
A3
3 66 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant 6*5*4 I 2+2
A4
4 66 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant 6*5*4 I 2+2
A5
5 73 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 3 4+3
A6
6 73 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 3 4+3
A7
7 68 M Prostate Adenocarcinoma - T2bN0M0 IIB Malignant 8*7*5 1 3+3
A8
8 68 M Prostate Adenocarcinoma - T2bN0M0 IIB Malignant 8*7*5 1 3+3
A9
9 69 M Prostate Adenocarcinoma - T3N0M0 III Malignant 4*3*2 1 3+3
A10
10 69 M Prostate Adenocarcinoma - T3N0M0 III Malignant 4*3*2 1 3+3
B1
11 73 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 5 4+5
B2
12 73 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 5 4+5
B3
13 81 M Prostate Adenocarcinoma - T3aN0M0 III Malignant 6*5*4 3 4+3
B4
14 81 M Prostate Adenocarcinoma - T3aN0M0 III Malignant 6*5*4 3 4+3
B5
15 60 M Prostate Adenocarcinoma - T2N0M0 II Malignant - 1 3+3
B6
16 60 M Prostate Adenocarcinoma - T2N0M0 II Malignant - 1 3+3
B7
17 73 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 4*3.5*3 2 3+4
B8
18 73 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 4*3.5*3 2 3+4
B9
19 69 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 6*6*4.5 4 4+4
B10
20 70 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 6*6*4.5 4 4+4
C1
21 60 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant 3*3*3 5 5+5
C2
22 61 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant 3*3*3 5 5+5
C3
23 80 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 5 5+4
C4
24 80 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 5 5+4
C5
25 66 M Prostate Adenocarcinoma - T2N0M0 I Malignant 3*2*1 3 4+3
C6
26 66 M Prostate Adenocarcinoma - T2N0M0 I Malignant 3*2*1 3 4+3
C7
27 70 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 4*2*2 3 4+3
C8
28 70 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 4*2*2 3 4+3
C9
29 75 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 2 3+4
C10
30 75 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 2 3+4
D1
31 61 M Prostate Adenocarcinoma - T3N1M0 IV Malignant - 4 4+4
D2
32 61 M Prostate Adenocarcinoma - T3N1M0 IV Malignant - 4 4+4
D3
33 62 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant 6*5*2 4 4+4
D4
34 62 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant 6*5*2 4 4+4
D5
35 70 M Prostate Adenocarcinoma - T3N0M0 III Malignant 7*3*3.5 4 4+4
D6
36 70 M Prostate Adenocarcinoma (sparse) - T3N0M0 III Malignant 7*3*3.5 4 4+4
D7
37 20 M Prostate Adenocarcinoma - T3N0M0 III Malignant 6*5*4 4 4+4
D8
38 20 M Prostate Adenocarcinoma - T3N0M1 III Malignant 6*5*4 4 4+4
D9
39 72 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant 5*3*2 5 5+4
D10
40 72 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant 5*3*2 5 5+4
E1
41 72 M Prostate Adenocarcinoma (sparse) - T3N0M0 III Malignant - 4 4+4
E2
42 72 M Prostate Adenocarcinoma - T3N0M0 III Malignant - - -
E3
43 60 M Prostate Adenocarcinoma - T3AN0M0 III Malignant - 5 4+5
E4
44 60 M Prostate Adenocarcinoma - T3AN0M0 III Malignant - 5 4+5
E5
45 74 M Prostate Adenocarcinoma * T2N0M0 II Malignant 6*4*3 - -
E6
46 74 M Prostate Adenocarcinoma - T2N0M0 II Malignant 6*4*3 5 4+5
E7
47 56 M Prostate Adenocarcinoma - T3N0M0 III Malignant 3*2.5 5 4+5
E8
48 56 M Prostate Adenocarcinoma - T3N0M0 III Malignant 3*2.5 5 4+5
E9
49 65 M Prostate Adenocarcinoma - T2N0M0 II Malignant 3*3*2 5 5+4
E10
50 65 M Prostate Adenocarcinoma - T2N0M0 II Malignant 3*3*2 5 5+4
F1
51 60 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 4 5+3
F2
52 60 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 4 5+3
F3
53 75 M Prostate Adenocarcinoma * T2N0M0 Malignant - - -
F4
54 75 M Prostate Adenocarcinoma * T2N0M0 Malignant - - -
F5
55 62 M Prostate Adenocarcinoma - T3N0M0 III Malignant 9*6*2.5 3 4+3
F6
56 62 M Prostate Adenocarcinoma - T3N0M0 III Malignant 9*6*2.5 3 4+3
F7
57 75 M Prostate Adenocarcinoma - T3N1M0 Malignant 5*2*2 5 5+5
F8
58 75 M Prostate Adenocarcinoma - T3N1M0 Malignant 5*2*2 5 5+5
F9
59 63 M Prostate Adenocarcinoma - T2N0M0 II Malignant - 5 5+5
F10
60 63 M Prostate Adenocarcinoma - T2N0M0 II Malignant - 5 5+5
G1
61 66 M Prostate Adenocarcinoma - T3aN0M0 III Malignant 4.5*4*4 5 5+4
G2
62 66 M Prostate Adenocarcinoma - T3aN0M0 III Malignant 4.5*4*4 5 5+4
G3
63 87 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 5 5+4
G4
64 87 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 5 5+4
G5
65 68 M Prostate Adenocarcinoma (degeneration and necrosis) * T2N0M0 IIA Malignant 5*4*4 - -
G6
66 68 M Prostate Adenocarcinoma (degeneration and necrosis) * T2N0M0 IIA Malignant 5*4*4 - -
G7
67 57 M Prostate Adenocarcinoma * T2aN0M0 IIA Malignant 3*4*4 - -
G8
68 57 M Prostate Adenocarcinoma (sparse) - T2aN0M0 IIA Malignant 3*4*4 4 4+4
G9
69 82 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 5 5+4
G10
70 82 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 5 5+4
H1
71 68 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H2
72 68 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H3
73 57 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H4
74 57 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H5
75 82 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H6
76 82 M Prostate Cancer adjacent prostate tissue - - - AT - - -
Find overlapping cases with this tissue array:
  • MPR761a
    File Format: .xlsx
    Release Date: 2025-01-17 16:04:24
    Download
0.527706s